Research progress on epigenetic in pulmonary arterial hypertension
10.3760/cma.j.issn.1673-4912.2024.08.014
- VernacularTitle:肺动脉高压发病机制中表观遗传学的研究进展
- Author:
Jie ZHANG
1
;
Youpeng JIN
;
Peng YANG
Author Information
1. 山东第一医科大学附属省立医院小儿重症医学科,济南 250021
- Keywords:
Epigenetics;
Pulmonary arterial hypertension;
DNA methylation;
Histone modifications;
Non-coding RNAs
- From:
Chinese Pediatric Emergency Medicine
2024;31(8):628-631
- CountryChina
- Language:Chinese
-
Abstract:
Pulmonary arterial hypertension(PAH)is a clinical syndrome characterized by increased pulmonary vascular resistance and elevated pulmonary arterial pressure,which subsequently leads to right heart failure and even death.PAH is caused by a variety of etiologic and pathogenic mechanisms,including congenital and acquired.Epigenetics is the study of the altered expression and function of genes that produce heritable phenotypes without changes in DNA sequence,and it bridges the relationship between environment and heredity.There is growing evidence that epigenetic modifications,including DNA methylation,histone modifications,and non-coding RNA,play important roles in the development of PAH.This review focused on the mechanisms and progress of epigenetic involvement in the development of PAH.